本期内容提示:
1、$Sierra Oncology(SRRA)、$安塔尔制药(ATRS)等多家药企被收购,医药板块是否会迎来反转契机?
2、今年商业化阶段的创新药药企受青睐,哪些公司值得配置?
3、$Protagonist(PTGX)暴跌,是否有抄底机会?
$百济神州-U(SH68823...查看全文
等等达文西2021-03-09 00:17
$安塔尔制药(ATRS)$ 5块是很强的阻力位,破了五块,应该能翻倍。 再观察观察,我可能会在4块附件捡一些仓位,毕竟这个货的业绩转强很多,希望能破五块。查看全文
5月11日,资本邦了解到,美股上市公司安塔尔制药(ATRS.US)发布2022财年一季报。 2022年1月1日-2022年3月31日,公司营业收入4155.70万美元,同比下降1.25%,归属母公司净亏损232.10万美元,同比止盈转亏,去年同期净利379.30万美元,基本每股收益为-0... 网页链接
$安塔尔制药(ATRS)$ 8-K - Current report Filed: 2019-03-04 AccNo: 0001564590-19-005951 Size: 80 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 7.01: Regulation F...
$安塔尔制药(ATRS)$ 内部交易: 2019-02-26,Director,GONELLA JACQUES ,卖出,200000普通股, $3.65
$安塔尔制药(ATRS)$ 8-K - Current report Filed: 2019-02-28 AccNo: 0001564590-19-005167 Size: 327 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$安塔尔制药(ATRS)$ 美东时间 2019-02-28 盘前 披露财报,预期EPS -0.03 网页链接
$安塔尔制药(ATRS)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0000919574-19-001695 Size: 111 KB 网页链接
$安塔尔制药(ATRS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-041213 Size: 41 KB 网页链接
$安塔尔制药(ATRS)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-04 AccNo: 0000215457-19-003140 Size: 13 KB 网页链接
$安塔尔制药(ATRS)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001564590-19-000268 Size: 9 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Antares Pharma, Inc.(ATRS)$ 8-K - Current report Filed: 2018-12-13 AccNo: 0001564590-18-030874 Size: 55 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Fi...
$Antares Pharma, Inc.(ATRS)$ 8-K - Current report Filed: 2018-11-15 AccNo: 0001193125-18-327214 Size: 11 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接